Viatris Cardura XL 8mg Tablets Recall: Impurities May Cause Harm

Take action

Contact the company & request your remedy

Recalling firmViatris Inc1000 Mylan Blvd · Canonsburg, PA 15317-5853

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Viatris is recalling Cardura XL 8mg extended-release tablets that were made in Singapore. The recall is due to failed impurities or degradation specifications, which could pose a health risk.

Why it’s dangerous

The tablets may contain impurities or degrade in a way that could cause health issues. This is a quality control issue that affects the safety of the medication.

Who’s affected

Prescription patients who have the specific lot numbers of Cardura XL 8mg tablets made in Singapore. Those with the lot numbers 8147041 (expiring June 2024) or 8163765 (expiring March 2025) are most at risk.

How to tell if you have this one

Check the product label for the lot number: 8147041 (expires June 2024) or 8163765 (expires March 2025). The product is a prescription medication made in Singapore by Viatris.

Brand
Viatris
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for the lot number on the label: 8147041 (expiring June 2024) or 8163765 (expiring March 2025).

✎ GovInfoNow

Questions people ask

What is the specific product being recalled?

Cardura XL 8mg extended-release tablets, 30-count bottles, made in Singapore with lot numbers 8147041 (expiring June 2024) or 8163765 (expiring March 2025).

How can I tell if I have the recalled product?

Check the product label for the lot number: 8147041 (expiring June 2024) or 8163765 (expiring March 2025).

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact Viatris directly for instructions.

Take action

Contact Viatris

We’ve drafted a message you can send Viatris to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0603-2024 — Viatris Viatris

Hello,

I own a Viatris that is covered by recall D-0603-2024 from Viatris.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0603-2024 (April 30, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0603-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig

Recall notice